LATITUDE Pharmaceuticals Develops an SC/IM Injectable Remdesivir Formulation
100 mg/mL Formulation Offers Significant Advantages for Dosing COVID-19 Patients SAN DIEGO, CALIFORNIA, US, May 5, 2020 /EINPresswire.com/ -- LATITUDE Pharmaceuticals Inc. (LATITUDE), a specialized drug formulation developer, announced today that it has …